(Q44127693)

30 November 2017

title

Gene expression signature-based prognostic risk score in patients with glioblastoma (English)

1 reference

30 November 2017

10

1 reference

30 November 2017

Atsushi Kawaguchi

1

1 reference

30 November 2017

Naoki Yajima

2

1 reference

30 November 2017

Naoto Tsuchiya

3

1 reference

30 November 2017

Jumpei Homma

4

1 reference

30 November 2017

Masakazu Sano

5

1 reference

30 November 2017

Manabu Natsumeda

6

1 reference

30 November 2017

Hitoshi Takahashi

7

1 reference

30 November 2017

Yukihiko Fujii

8

1 reference

30 November 2017

Tatsuyuki Kakuma

9

1 reference

30 November 2017

publication date

5 July 2013

1 reference

30 November 2017

1 reference

30 November 2017

volume

104

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

1205-1210

1 reference

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

30 November 2017

cites work

1 reference

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Gene expression profiling of gliomas strongly predicts survival

21 January 2018

1 reference

Gene expression profiling and genetic markers in glioblastoma survival.

21 January 2018

1 reference

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

Identification of expressed genes characterizing long-term survival in malignant glioma patients

21 January 2018

1 reference

Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data

21 January 2018

1 reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas

21 January 2018

1 reference

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

Relative Risk Trees for Censored Survival Data

21 January 2018

1 reference

Detecting gene-gene interactions that underlie human diseases

21 January 2018

1 reference

Gene expression signature-based prognostic risk score in patients with primary central nervous system lymphoma

21 January 2018

1 reference

Index for rating diagnostic tests

21 January 2018

1 reference

12 December 2020

Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients.

1 reference

12 December 2020

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

1 reference

12 December 2020

Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes.

1 reference

12 December 2020

Identifiers

DOI

10.1111/CAS.12214

1 reference

30 November 2017

0 references

1 reference